NLS Pharmaceutics AG
0.01
-0.01 (-42.86%)
At close: Jan 15, 2025, 12:42 PM
0.01
0.00%
After-hours Jan 15, 2025, 12:42 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 11.41K 11.41K 10.05K n/a n/a n/a n/a
Gross Profit -11.41K -11.41K -10.05K n/a n/a n/a n/a
Operating Income -11.81M -15.48M -11.86M -2.30M -4.20M -3.45M -5.77M
Interest Income n/a 100.87 68.13 233.70 819.71 16.04K 890.40
Pretax Income -12.17M -16.50M -11.95M -2.86M -5.45M -5.15M -6.66M
Net Income -12.17M -16.50M -11.95M -2.86M -5.45M -5.15M -6.66M
Selling & General & Admin 5.90M 6.49M 5.93M 2.20M 2.49M 2.01M 1.44M
Research & Development 5.91M 8.98M 5.92M 99.58K 1.70M 1.44M 4.32M
Other Expenses 0.00 10.04K -17.32K -328.37K n/a -629.23K n/a
Operating Expenses 11.81M 15.47M 11.85M 2.30M 4.20M 3.45M 5.77M
Interest Expense 145.15K 100.87K 68.13K 233.70K 819.71K 1.07M 890.40K
Selling & Marketing Expenses n/a 6.49M 5.93M 2.20M 2.49M n/a n/a
Cost & Expenses 11.81M 15.48M 11.86M 2.30M 4.20M 3.45M 5.77M
Income Tax n/a 2.00 -226.51K -2.30K -4.20K 1.70M -5.77K
Shares Outstanding (Basic) 38.18M 19.68M 14.75M 4.82M 11.14M 11.78M 11.78M
Shares Outstanding (Diluted) 38.18M 19.68M 14.75M 4.82M 11.14M 11.78M 11.78M
EPS (Basic) -0.32 -0.84 -0.81 -0.59 -0.49 -0.44 -0.57
EPS (Diluted) -0.32 -0.84 -0.81 -0.59 -0.49 -0.44 -0.57
EBITDA -11.80M -15.47M -11.85M n/a -430.40K -613.20K -5.77M
Depreciation & Amortization 11.41K 11.41K 10.05K 2.30M 4.20M 3.45M 5.77M